Overview

A virtual Experts Knowledge Share on the topic of ‘HER2 testing: The evolving role of immunohistochemistry - best practices and interpretation of results in lung and ovarian cancer’, chaired by Prof. Fernando López-Ríos (Spain) and co-chaired by Prof. Charlie Gourley (UK) and Prof. Christian Rolfo (US).  

Topics of conversation include: 

1. An overview of challenges related to HER2 immunohistochemistry, practical guidance and interpretation of the results
2. Targeting HER2 in lung cancer: where does IHC testing fit in?
3. Ovarian cancer: Challenges and considerations for HER2 IHC testing
4. A panel discussion amongst speakers and participants engaging in a Q&A to address pressing issues

This event is in collaboration with PRECISION ONCOLOGY CONNECT, a group of international experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers. 

Don’t miss the opportunity to contribute to the discussion on this important topic.  

This programme is supported by an Independent Medical Education Grant from AstraZeneca.

For more information please visit the official event page.